Denmark’s Zealand Pharma and Chinese biotech OTR Therapeutics have announced a multi-program strategic collaboration and ...

Swiss clinical-stage biotech AC Immune today announced positive interim safety and efficacy results from the Phase II VacSYn ...

US pharma major Bristol Myers Squibb has announced progress for its multi-indication cancer drug Opdivo (nivolumab) in ...

The diagnosed prevalent cases of diabetic macular edema (DME) in the diabetes population across the seven major markets (7MM: ...

Swiss pharma giant Roche (SIX: ROG) has announced positive data from the Phase III lidERA Breast Cancer study of giredestrant ...

Switzerland-based Roivant hosted an Investor Day in New York City today, highlighting its leadership with key pipeline ...

For decades, the generics industry has been dedicated to supporting the financial sustainability of health systems. By ...

The bipolar disorder market across the USA, Europe, and Japan is forecast to rise from $5.6 billion in 2024 to $9.4 billion ...

German biotech Disco Pharmaceuticals has appointed Mark Manfredi as chief executive and closed a 36 million euro ($39 million ...

Diakonos Oncology has received more than $7 million from the Cancer Prevention and Research Institute of Texas to support a ...

Hong Kong-based Ascletis Pharma has announced that its New Drug Application (NDA) for denifanstat (ASC40), a first-in-class, ...

As a physical embodiment of the ambition of Accord Healthcare to establish itself as a leader in the global health landscape, the company’s new office in Stockley Park, London, is as impressive as it ...